Ankylosing spondylitis macrophage production of higher levels of interleukin-23 in response to lipopolysaccharide without induction of a significant unfolded protein response

Arthritis and Rheumatism

Volumn 63, Issue 12, 2011, Pages 3807-3817

  Zeng, Ling ^a   Lindstrom, Mary J ^a   Smith, Judith A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CCAAT ENHANCER BINDING PROTEIN; CCAAT ENHANCER BINDING PROTEIN HOMOLOGOUS PROTEIN 10; CXCL9 CHEMOKINE; GAMMA INTERFERON; GLUCOSE REGULATED PROTEIN 78; HLA B ANTIGEN; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 23; LIPOPOLYSACCHARIDE; PEPTIDES AND PROTEINS; PROTEIN ERDJ4; UNCLASSIFIED DRUG;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; MACROPHAGE; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNFOLDED PROTEIN RESPONSE;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; CCAAT-ENHANCER-BINDING PROTEINS; CELLS, CULTURED; CHEMOKINES; CYTOKINES; FEMALE; HLA-B ANTIGENS; HUMANS; INTERFERON-GAMMA; INTERLEUKIN-23; LIPOPOLYSACCHARIDES; MACROPHAGES; MALE; MIDDLE AGED; OLIGOPEPTIDES; SPONDYLITIS, ANKYLOSING; TRANSCRIPTION FACTOR CHOP; UNFOLDED PROTEIN RESPONSE; YOUNG ADULT;

EID: 82455210509     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.30593     Document Type: Article

References (46)

1. Sieper J, Braun J, Rudwaleit M, Boonen A, Zink A,. Ankylosing spondylitis: an overview. Ann Rheum Dis 2002; 61 Suppl III: iii8-18. (Pubitemid 35397340)
2. Boonen A, Severens JL,. Ankylosing spondylitis: what is the cost to society, and can it be reduced? Best Pract Res Clin Rheumatol 2002; 16: 691-705.
3. Reveille JD,. The genetic basis of ankylosing spondylitis. Curr Opin Rheumatol 2006; 18: 332-41. (Pubitemid 44297276)
4. Braun J, Bollow M, Remlinger G, Eggens U, Rudwaleit M, Distler A, et al. Prevalence of spondylarthropathies in HLA-B27 positive and negative blood donors. Arthritis Rheum 1998; 41: 58-67. (Pubitemid 28041923)
5. Van der Linden SM, Valkenburg HA, de Jongh BM, Cats A,. The risk of developing ankylosing spondylitis in HLA-B27 positive individuals: a comparison of relatives of spondylitis patients with the general population. Arthritis Rheum 1984; 27: 241-9. (Pubitemid 14163215)
6. Brown MA,. Genetics and the pathogenesis of ankylosing spondylitis. Curr Opin Rheumatol 2009; 21: 318-23.
7. 2m: an animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112. (Pubitemid 120034950)
8. Smith JA, Marker-Hermann E, Colbert RA,. Pathogenesis of ankylosing spondylitis: current concepts. Best Pract Res Clin Rheumatol 2006; 20: 571-91. (Pubitemid 44182767)
9. May E, Dorris ML, Satumtira N, Iqbal I, Rehman MI, Lightfoot E, et al. CD8αβ T cells are not essential to the pathogenesis of arthritis or colitis in HLA-B27 transgenic rats. J Immunol 2003; 170: 1099-105. (Pubitemid 36070566)
10. Mear JP, Schreiber KL, Munz C, Zhu X, Stevanovic S, Rammensee HG, et al. Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies. J Immunol 1999; 163: 6665-70.
11. Dangoria NS, DeLay ML, Kingsbury DJ, Mear JP, Uchanska-Ziegler B, Ziegler A, et al. HLA-B27 misfolding is associated with aberrant intermolecular disulfide bond formation (dimerization) in the endoplasmic reticulum. J Biol Chem 2002; 277: 23459-68. (Pubitemid 34952180)
12. 2-microglobulin-free heavy chain homodimer structure. J Immunol 1999; 162: 5045-8. (Pubitemid 29307101)
13. Kollnberger S, Bird LA, Roddis M, Hacquard-Bouder C, Kubagawa H, Bodmer HC, et al. HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors. J Immunol 2004; 173: 1699-710. (Pubitemid 38971601)
14. Chan AT, Kollnberger SD, Wedderburn LR, Bowness P,. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 2005; 52: 3586-95. (Pubitemid 41612228)
15. Schroder M, Kaufman RJ,. The mammalian unfolded protein response. Annu Rev Biochem 2005; 74: 739-89. (Pubitemid 40995523)
16. Turner MJ, Sowders DP, DeLay ML, Mohapatra R, Bai S, Smith JA, et al. HLA-B27 misfolding in transgenic rats is associated with activation of the unfolded protein response. J Immunol 2005; 175: 2438-48. (Pubitemid 41113854)
17. Turner MJ, Delay ML, Bai S, Klenk E, Colbert RA,. HLA-B27 up-regulation causes accumulation of misfolded heavy chains and correlates with the magnitude of the unfolded protein response in transgenic rats: implications for the pathogenesis of spondylarthritis-like disease. Arthritis Rheum 2007; 56: 215-23. (Pubitemid 46106195)
18. Gu J, Rihl M, Marker-Hermann E, Baeten D, Kuipers JG, Song YW, et al. Clues to pathogenesis of spondyloarthropathy derived from synovial fluid mononuclear cell gene expression profiles. J Rheumatol 2002; 29: 2159-64.
19. 2-microglobulin curbs HLA-B27 misfolding and promotes arthritis and spondylitis without colitis in male HLA-B27-transgenic rats. Arthritis Rheum 2006; 54: 1317-27. (Pubitemid 43672945)
20. Smith JA, Turner MJ, DeLay ML, Klenk EI, Sowders DP, Colbert RA,. Endoplasmic reticulum stress and the unfolded protein response are linked to synergistic IFN-β induction via X-box binding protein 1. Eur J Immunol 2008; 38: 1194-203.
21. DeLay ML, Turner MJ, Klenk EI, Smith JA, Sowders DP, Colbert RA,. HLA-B27 misfolding and the unfolded protein response augment interleukin-23 production and are associated with Th17 activation in transgenic rats. Arthritis Rheum 2009; 60: 2633-43.
22. H-17 cells in the circle of immunity and autoimmunity. Nat Immunol 2007; 8: 345-50. (Pubitemid 46745409)
23. Shen H, Goodall JC, Gaston JS,. Frequency and phenotype of peripheral blood Th17 cells in ankylosing spondylitis and rheumatoid arthritis. Arthritis Rheum 2009; 60: 1647-56.
24. Ciccia F, Bombardieri M, Principato A, Giardina A, Tripodo C, Porcasi R, et al. Overexpression of interleukin-23, but not interleukin-17, as an immunologic signature of subclinical intestinal inflammation in ankylosing spondylitis. Arthritis Rheum 2009; 60: 955-65.
25. Bollow M, Fischer T, Reisshauer H, Backhaus M, Sieper J, Hamm B, et al. Quantitative analyses of sacroiliac biopsies in spondyloarthropathies: T cells and macrophages predominate in early and active sacroiliitis-cellularity correlates with the degree of enhancement detected by magnetic resonance imaging. Ann Rheum Dis 2000; 59: 135-40. (Pubitemid 30305612)
26. Van der Linden S, Valkenburg HA, Cats A,. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum 1984; 27: 361-8. (Pubitemid 14134775)
27. Bon MA, van Oeveren-Dybicz A, van den Bergh FA,. Genotyping of HLA-B27 by real-time PCR without hybridization probes. Clin Chem 2000; 46: 1000-2. (Pubitemid 30461274)
28. Smith JA, Barnes MD, Hong D, DeLay ML, Inman RD, Colbert RA,. Gene expression analysis of macrophages derived from ankylosing spondylitis patients reveals interferon-γ dysregulation. Arthritis Rheum 2008; 58: 1640-9. (Pubitemid 351847516)
29. Cauli A, Dessole G, Fiorillo MT, Vacca A, Mameli A, Bitti P, et al. Increased level of HLA-B27 expression in ankylosing spondylitis patients compared with healthy HLA-B27-positive subjects: a possible further susceptibility factor for the development of disease. Rheumatology (Oxford) 2002; 41: 1375-9. (Pubitemid 36004313)
30. Lee AH, Iwakoshi NN, Glimcher LH,. XBP-1 regulates a subset of endoplasmic reticulum resident chaperone genes in the unfolded protein response. Mol Cell Biol 2003; 23: 7448-59. (Pubitemid 37271447)
31. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A, Mori K,. ATF6 is a transcription factor specializing in the regulation of quality control proteins in the endoplasmic reticulum. Cell Struct Funct 2008; 33: 75-89. (Pubitemid 351860903)
32. Martinon F, Chen X, Lee AH, Glimcher LH,. TLR activation of the transcription factor XBP1 regulates innate immune responses in macrophages. Nat Immunol 2010; 11: 411-8.
33. De Castro JA,. HLA-B27-bound peptide repertoires: their nature, origin and pathogenetic relevance. Adv Exp Med Biol 2009; 649: 196-209.
34. Kim TH, Uhm WS, Inman RD,. Pathogenesis of ankylosing spondylitis and reactive arthritis. Curr Opin Rheumatol 2005; 17: 400-5. (Pubitemid 41058398)
35. Rudwaleit M, Siegert S, Yin Z, Eick J, Thiel A, Radbruch A, et al. Low T cell production of TNFα and IFNγ in ankylosing spondylitis: its relation to HLA-B27 and influence of the TNF-308 gene polymorphism. Ann Rheum Dis 2001; 60: 36-42. (Pubitemid 32038951)
36. Brand JM, Neustock P, Kruse A, Alvarez-Ossorio L, Schnabel A, Kirchner H,. Stimulation of whole blood cultures in patients with ankylosing spondylitis by a mitogen derived from Mycoplasma arthritidis (MAS) and other mitogens. Rheumatol Int 1997; 16: 207-11. (Pubitemid 27060931)
37. Loos T, Dekeyzer L, Struyf S, Schutyser E, Gijsbers K, Gouwy M, et al. TLR ligands and cytokines induce CXCR3 ligands in endothelial cells: enhanced CXCL9 in autoimmune arthritis. Lab Invest 2006; 86: 902-16. (Pubitemid 44268165)
38. Keller C, Webb A, Davis J,. Cytokines in the seronegative spondyloarthropathies and their modification by TNF blockade: a brief report and literature review. Ann Rheum Dis 2003; 62: 1128-32. (Pubitemid 37500615)
39. Wendling D, Cedoz JP, Racadot E,. Serum and synovial fluid levels of p40 IL12/23 in spondyloarthropathy patients. Clin Rheumatol 2009; 28: 187-90.
40. Proost P, Struyf S, Loos T, Gouwy M, Schutyser E, Conings R, et al. Coexpression and interaction of CXCL10 and CD26 in mesenchymal cells by synergising inflammatory cytokines: CXCL8 and CXCL10 are discriminative markers for autoimmune arthropathies. Arthritis Res Ther 2006; 8: R107.
41. Goodall JC, Wu C, Zhang Y, McNeill L, Ellis L, Saudek V, et al. Endoplasmic reticulum stress-induced transcription factor, CHOP, is crucial for dendritic cell IL-23 expression. Proc Natl Acad Sci U S A 2010; 107: 17698-703.
42. Cooper AM,. IL-17 and anti-bacterial immunity: protection versus tissue damage. Eur J Immunol 2009; 39: 649-52.
43. Reveille JD, Sims AM, Danoy P, Evans DM, Leo P, Pointon JJ, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet 2010; 42: 123-7.
44. Wang X, Lin Z, Wei Q, Jiang Y, Gu J,. Expression of IL-23 and IL-17 and effect of IL-23 on IL-17 production in ankylosing spondylitis. Rheumatol Int 2009; 29: 1343-7.
45. Griffiths CE, Strober BE, van de Kerkhof P, Ho V, Fidelus-Gort R, Yeilding N, et al, for the ACCEPT Study Group. Comparison of ustekinumab and etanercept for moderate-to-severe psoriasis. N Engl J Med 2010; 362: 118-28.
46. Heldmann F, Dybowski F, Saracbasi-Zender E, Fendler C, Braun J,. Update on biologic therapy in the management of axial spondyloarthritis. Curr Rheumatol Rep. 2010; 12: 325-31.